Effects of race on lipid-lowering management in hospitalized patients with coronary heart disease

被引:4
|
作者
Dressler, DD
Jacobson, TA
机构
[1] Emory Univ, Sch Med, Dept Med, Div Gen Med, Atlanta, GA 30303 USA
[2] Hosp Med Unit, Atlanta, GA USA
[3] Off Hlth Promot & Dis Prevent, Grady Hlth Syst, Atlanta, GA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 09期
关键词
D O I
10.1016/j.amjcard.2004.01.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to determine the association between patient characteristics, specifically race, and the appropriate management of lipid-reducing therapy in patients with coronary heart disease (CHD) discharged from the hospital. Two hundred fifty-eight consecutive patients with diagnoses suggestive of CHD were identified in a large, inner-city university teaching hospital serving a predominantly indigent African American population. The outcome measure, suboptimal lipid management, evaluated the intensification of lipid-reducing therapy when indicated using the National Cholesterol Education Program guidelines for the low-density lipoprotein cholesterol goal. The overall rate of suboptimal lipid management was 48%. Black patients with CHD were significantly more likely to have suboptimal lipid management than nonblack patients by the time of hospital discharge (52.3% vs 16.7%, p = 0.021). The disparity in the clinical management of black patients with CHD may help explain the differential in health outcomes seen between black and white patients. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:1167 / 1170
页数:4
相关论文
共 50 条
  • [21] Effects of lipid-lowering treatment on coronary perfusion
    Steinmetz, A
    Maisch, B
    Noll, B
    ZEITSCHRIFT FUR KARDIOLOGIE, 1997, 86 : 43 - 55
  • [22] Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
    Rosen, Virginia M.
    Taylor, Douglas C. A.
    Parekh, Hemangi
    Pandya, Ankur
    Thompson, David
    Kuznik, Andreas
    Waters, David D.
    Drummond, Michael
    Weinstein, Milton C.
    PHARMACOECONOMICS, 2010, 28 (01) : 47 - 60
  • [23] Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
    Virginia M. Rosen
    Douglas C. A. Taylor
    Hemangi Parekh
    Ankur Pandya
    David Thompson
    Andreas Kuznik
    David D. Waters
    Michael Drummond
    Milton C. Weinstein
    PharmacoEconomics, 2010, 28 : 47 - 60
  • [24] Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
    Mal'gina, M. P.
    Ignatyeva, O. I.
    Moroshkina, N. V.
    Skorobogatova, Yu. V.
    Nedoshivin, A. O.
    Berkovich, O. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (03): : 50 - 55
  • [25] Lipid-lowering benefits 'average' older patients without heart disease
    不详
    GERIATRICS, 1997, 52 (12) : 58 - 58
  • [26] Lipid-lowering therapies in the management of acute coronary syndromes
    Mosca L.
    Biviano A.
    Current Cardiology Reports, 2002, 4 (4) : 320 - 326
  • [27] Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease
    Wittlinger, Thomas
    Schwaab, Bernhard
    Voeller, Heinz
    Bongarth, Christa
    Heinze, Viktoria
    Eckrich, Kristina
    Guha, Manju
    Richter, Michael
    Schlitt, Axel
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (09)
  • [28] Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy
    Isles, CG
    Paterson, JR
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (09) : 567 - 574
  • [29] Underutilization of lipid-lowering therapy in coronary artery disease
    Batalla, A
    Hevia, S
    Reguero, JR
    Cubero, GI
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2683 - +
  • [30] Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics - The ALLIANCE study
    Koren, MJ
    Hunninghake, DB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1772 - 1779